These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 2843138

  • 21. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C, Agawa H, Sairenji T, Inoue Y.
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [Abstract] [Full Text] [Related]

  • 22. Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer.
    Miller G, Grogan E, Fischer DK, Niederman JC, Schooley RT, Henle W, Lenoir G, Liu CR.
    N Engl J Med; 1985 Mar 21; 312(12):750-5. PubMed ID: 2983211
    [Abstract] [Full Text] [Related]

  • 23. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.
    AIDS; 2007 Oct 18; 21(16):2141-9. PubMed ID: 18090040
    [Abstract] [Full Text] [Related]

  • 24. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov 18; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 25. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
    Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, Yang CS, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 2009 Apr 18; 18(4):1218-26. PubMed ID: 19336547
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842
    [Abstract] [Full Text] [Related]

  • 27. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O, Mollat C, N'Guyen JM, Billaudel S, Litoux P, Dréno B.
    Br J Dermatol; 1997 Feb 01; 136(2):212-6. PubMed ID: 9068734
    [Abstract] [Full Text] [Related]

  • 28. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov 01; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May 01; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 31. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA.
    Head Neck; 2004 Jul 01; 26(7):598-602. PubMed ID: 15229902
    [Abstract] [Full Text] [Related]

  • 32. Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.
    Sakamoto K, Seeley JK, Lindsten T, Sexton J, Yetz J, Ballow M, Purtilo DT.
    J Immunol; 1982 Feb 01; 128(2):904-7. PubMed ID: 6274962
    [Abstract] [Full Text] [Related]

  • 33. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.
    Ferrell PB, Aitcheson CT, Pearson GR, Tan EM.
    J Clin Invest; 1981 Mar 01; 67(3):681-7. PubMed ID: 6259207
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
    Dölken G, Boldt C, Lange W, Weitzmann U, Löhr GW, Rosén A.
    Cancer Detect Prev; 1983 Mar 01; 6(1-2):287-92. PubMed ID: 6309387
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus-related persistent erythema multiforme in chronic fatigue syndrome.
    Drago F, Romagnoli M, Loi A, Rebora A.
    Arch Dermatol; 1992 Feb 01; 128(2):217-22. PubMed ID: 1310844
    [Abstract] [Full Text] [Related]

  • 37. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP, Hilgers R, Skvaril F.
    Clin Exp Immunol; 1982 Jul 01; 49(1):149-56. PubMed ID: 6290114
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S, Schwarz G, Moneke D, Binder L, Müller G, Reuss-Borst M.
    J Rheumatol; 2000 Apr 01; 27(4):866-73. PubMed ID: 10782808
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
    Roubalová K, Weinreb M, Roubal J, Kodet R, Koutecký J, Vonka V.
    Acta Virol; 1988 Jul 01; 32(4):339-48. PubMed ID: 2903639
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD.
    J Med Virol; 2002 Jul 01; 67(3):320-6. PubMed ID: 12116021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.